Clinical Trials Directory

Trials / Sponsors / Byondis B.V.

Byondis B.V.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingA Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Meta
Solid Tumor
Phase 12025-05-07
Active Not RecruitingSafety, Pharmacokinetics, and Preliminary Efficacy of BYON4413 in Acute Myeloid Leukemia and Myelodysplastic N
Relapsed / Refractory AML, Relapsed / Refractory MDS
Phase 12024-06-25
Active Not RecruitingFirst-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228
Lymphoma
Phase 12024-03-04
CompletedA First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate BYON3521
Solid Tumor
Phase 12022-03-21
CompletedEvaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Canc
Metastatic Breast Cancer
Phase 1 / Phase 22022-01-10
CompletedPhase I Study of SYD985 With Niraparib in Patients With Solid Tumors
Solid Tumor
Phase 12020-06-22
CompletedSYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
Endometrial Cancer
Phase 22020-05-28
CompletedA First-in-human Dose-escalation and Expansion Study With the Antibody-drug Conjugate SYD1875
Solid Tumor
Phase 12020-02-28
CompletedSYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Metastatic Breast Cancer
Phase 32017-12-15
CompletedFirst-in-human Study With the Antibody-drug Conjugate SYD985 to Evaluate Safety and Efficacy in Cancer Patient
Solid Tumors
Phase 12014-10-01